Reduction of cardiovascular risk and improved estimated glomerular filtration rate by SGLT2 inhibitors, including dapagliflozin, is consistent across the class: an analysis of the placebo arm of EXSCEL
Semaglutide zmniejsza apetyt i daje organizmowi sygnay o sytoci, co sprzyja zdrowemu chudniciu
Barker BF, Carpenter WM, Daniels TE, Kahn MA, Leider AS, Lozada-Nur F, et al
Related Articles 'Deeply difficult': Doug Ingram to exit Sarepta CEO 'Deeply difficult': Doug Ingram to exit Sarepta CEO Colleges carve campuses, enroll seniors for revenue Colleges carve campuses, enroll seniors for revenue GSK buys Montreal-Boston biotech for nearly $1B GSK buys Montreal-Boston biotech for nearly $1B Healey urges state health plan board to halt cost shifts onto workers Healey urges state health plan board to halt cost shifts onto workers Private equity firm closes new fund, targets consumer products Private equity firm closes new fund, targets consumer products